WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (602)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, S. W.
Right arrow Articles by North, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, S. W.
Right arrow Articles by North, R. A.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 12, 483-488, Copyright © 1992 by Society for Neuroscience


ARTICLE

Opioids excite dopamine neurons by hyperpolarization of local interneurons

SW Johnson and RA North
Vollum Institute, Oregon Health Sciences University, Portland 97201.

Increased activity of dopamine-containing neurons in the ventral tegmental area is necessary for the reinforcing effects of opioids and other abused drugs. Intracellular recordings from these cells in slices of rat brain in vitro showed that opioids do not affect the principal (dopamine-containing) neurons but hyperpolarize secondary (GABA- containing) interneurons. Experiments with agonists and antagonists selective for opioid receptor subtypes indicated that the hyperpolarization of secondary cells involved the mu-receptor. Most principal cells showed spontaneous bicuculline-sensitive synaptic potentials when the extracellular potassium concentration was increased from 2.5 to 6.5 or 10.5 mM; these were prevented by TTX and assumed to result from action potentials arising in slightly depolarized local interneurons. The frequency of these synaptic potentials, but not their amplitudes, was reduced by opioids selective for mu-receptors. It is concluded that hyperpolarization of the interneurons by opioids reduces the spontaneous GABA-mediated synaptic input to the dopamine cells. In vivo, this would lead to excitation of the dopamine cells by disinhibition, which would be expected to contribute to the positive reinforcement seen with mu-receptor agonists such as morphine and heroin.


This article has been cited by other articles:


Home page
J. Neurosci.Home page
Z. B. Andrews, D. Erion, R. Beiler, Z.-W. Liu, A. Abizaid, J. Zigman, J. D. Elsworth, J. M. Savitt, R. DiMarchi, M. Tschop, et al.
Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism
J. Neurosci., November 11, 2009; 29(45): 14057 - 14065.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. W. Theile, H. Morikawa, R. A. Gonzales, and R. A. Morrisett
Role of 5-Hydroxytryptamine2C Receptors in Ca2+-Dependent Ethanol Potentiation of GABA Release onto Ventral Tegmental Area Dopamine Neurons
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 625 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. H. Good and C. R. Lupica
Properties of distinct ventral tegmental area synapses activated via pedunculopontine or ventral tegmental area stimulation in vitro
J. Physiol., March 15, 2009; 587(6): 1233 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Steidl and J. S. Yeomans
M5 Muscarinic Receptor Knockout Mice Show Reduced Morphine-Induced Locomotion but Increased Locomotion after Cholinergic Antagonism in the Ventral Tegmental Area
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 263 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. B. Margolis, H. L. Fields, G. O. Hjelmstad, and J. M. Mitchell
{delta}-Opioid Receptor Expression in the Ventral Tegmental Area Protects Against Elevated Alcohol Consumption
J. Neurosci., November 26, 2008; 28(48): 12672 - 12681.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
C. H. Yang, B. H. Lee, and S. H. Sohn
A Possible Mechanism Underlying the Effectiveness of Acupuncture in the Treatment of Drug Addiction
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 257 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Shabat-Simon, D. Levy, A. Amir, M. Rehavi, and A. Zangen
Dissociation between Rewarding and Psychomotor Effects of Opiates: Differential Roles for Glutamate Receptors within Anterior and Posterior Portions of the Ventral Tegmental Area
J. Neurosci., August 20, 2008; 28(34): 8406 - 8416.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. Bjork, R. Rimondini, A. C. Hansson, A. Terasmaa, P. Hyytia, M. Heilig, and W. H. Sommer
Modulation of voluntary ethanol consumption by beta-arrestin 2
FASEB J, July 1, 2008; 22(7): 2552 - 2560.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Cs. Horvath, G. G. Kovacs, V. Kovari, K. Majtenyi, Y. L. Hurd, and E. Keller
Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age
J. Neurosci., December 5, 2007; 27(49): 13371 - 13375.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ogawa, T. Miyakawa, K. Nakamura, J. Kitano, K. Furushima, H. Kiyonari, R. Nakayama, K. Nakao, K. Moriyoshi, and S. Nakanishi
Altered sensitivities to morphine and cocaine in scaffold protein tamalin knockout mice
PNAS, September 11, 2007; 104(37): 14789 - 14794.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego
The Endomorphin System and Its Evolving Neurophysiological Role
Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
C. S. Barr, M. Schwandt, S. G. Lindell, S. A. Chen, D. Goldman, S. J. Suomi, J. D. Higley, and M. Heilig
Association of a Functional Polymorphism in the {micro}-Opioid Receptor Gene With Alcohol Response and Consumption in Male Rhesus Macaques
Arch Gen Psychiatry, March 1, 2007; 64(3): 369 - 376.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z.-Q. Wu, J. Chen, Z.-Q. Chi, and J.-G. Liu
Involvement of Dopamine System in Regulation of Na+,K+-ATPase in the Striatum upon Activation of Opioid Receptors by Morphine
Mol. Pharmacol., February 1, 2007; 71(2): 519 - 530.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
S. E. Hyman
Addiction: A Disease of Learning and Memory
Focus, January 1, 2007; 5(2): 220 - 228.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. P. Ford, M. J. Beckstead, and J. T. Williams
Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents
J Neurophysiol, January 1, 2007; 97(1): 883 - 891.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. B. Margolis, H. Lock, G. O. Hjelmstad, and H. L. Fields
The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?
J. Physiol., December 15, 2006; 577(3): 907 - 924.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Georges, C. L. Moine, and G. Aston-Jones
No Effect of Morphine on Ventral Tegmental Dopamine Neurons during Withdrawal
J. Neurosci., May 24, 2006; 26(21): 5720 - 5726.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Salomon, C. Lanteri, J. Glowinski, and J.-P. Tassin
Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons
PNAS, May 9, 2006; 103(19): 7476 - 7481.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. P. Ford, G. P. Mark, and J. T. Williams
Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.
J. Neurosci., March 8, 2006; 26(10): 2788 - 2797.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. B. Margolis, H. Lock, V. I. Chefer, T. S. Shippenberg, G. O. Hjelmstad, and H. L. Fields
{kappa} opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
PNAS, February 21, 2006; 103(8): 2938 - 2942.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. E. Hyman
Addiction: A Disease of Learning and Memory
Am J Psychiatry, August 1, 2005; 162(8): 1414 - 1422.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. Muller and E. M. Unterwald
D1 Dopamine Receptors Modulate {Delta}FosB Induction in Rat Striatum after Intermittent Morphine Administration
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. D. Mansvelder
Yin and Yang of VTA Opioid Signaling. Focus on "Both Kappa and Mu Opioid Agonists Inhibit Glutamatergic Input to Ventral Tegmental Area Neurons"
J Neurophysiol, June 1, 2005; 93(6): 3046 - 3047.
[Full Text] [PDF]


Home page
J. Neurophysiol.Home page
E. B. Margolis, G. O. Hjelmstad, A. Bonci, and H. L. Fields
Both Kappa and Mu Opioid Agonists Inhibit Glutamatergic Input to Ventral Tegmental Area Neurons
J Neurophysiol, June 1, 2005; 93(6): 3086 - 3093.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. McDaid, J. E. Dallimore, A. R. Mackie, A. L. Mickiewicz, and T. C. Napier
Cross-Sensitization to Morphine in Cocaine-Sensitized Rats: Behavioral Assessments Correlate with Enhanced Responding of Ventral Pallidal Neurons to Morphine and Glutamate, with Diminished Effects of GABA
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1182 - 1193.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. A. Taha and H. L. Fields
Encoding of Palatability and Appetitive Behaviors by Distinct Neuronal Populations in the Nucleus Accumbens
J. Neurosci., February 2, 2005; 25(5): 1193 - 1202.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. Muller and E. M. Unterwald
In Vivo Regulation of Extracellular Signal-Regulated Protein Kinase (ERK) and Protein Kinase B (Akt) Phosphorylation by Acute and Chronic Morphine
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 774 - 782.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Ikemoto, B. M. Witkin, A. Zangen, and R. A. Wise
Rewarding Effects of AMPA Administration into the Supramammillary or Posterior Hypothalamic Nuclei But Not the Ventral Tegmental Area
J. Neurosci., June 23, 2004; 24(25): 5758 - 5765.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
M. A. Dawes and B. A. Johnson
PHARMACOTHERAPEUTIC TRIALS IN ADOLESCENT ALCOHOL USE DISORDERS: OPPORTUNITIES AND CHALLENGES
Alcohol Alcohol., May 1, 2004; 39(3): 166 - 177.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. J. Michel, J. M. Robillard, and L.-E. Trudeau
Regulation of rat mesencephalic GABAergic neurones through muscarinic receptors
J. Physiol., April 15, 2004; 556(2): 429 - 445.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Kim, K. A. Pollak, G. O. Hjelmstad, and H. L. Fields
A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism
PNAS, April 13, 2004; 101(15): 5664 - 5669.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Nagai, K. Yamada, M. Yoshimura, K. Ishikawa, Y. Miyamoto, K. Hashimoto, Y. Noda, A. Nitta, and T. Nabeshima
From The Cover: The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release
PNAS, March 9, 2004; 101(10): 3650 - 3655.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Leite-Morris, E. Y. Fukudome, M. H. Shoeb, and G. B. Kaplan
GABAB Receptor Activation in the Ventral Tegmental Area Inhibits the Acquisition and Expression of Opiate-Induced Motor Sensitization
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 667 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. M. Bohn, R. R. Gainetdinov, T. D. Sotnikova, I. O. Medvedev, R. J. Lefkowitz, L. A. Dykstra, and M. G. Caron
Enhanced Rewarding Properties of Morphine, but not Cocaine, in {beta}arrestin-2 Knock-Out Mice
J. Neurosci., November 12, 2003; 23(32): 10265 - 10273.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. B. Margolis, G. O. Hjelmstad, A. Bonci, and H. L. Fields
{kappa}-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
J. Neurosci., November 5, 2003; 23(31): 9981 - 9986.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Backes and S. E. Hemby
Discrete Cell Gene Profiling of Ventral Tegmental Dopamine Neurons after Acute and Chronic Cocaine Self-Administration
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 450 - 459.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. Bolanos, L. I. Perrotti, S. Edwards, A. J. Eisch, M. Barrot, V. G. Olson, D. S. Russell, R. L. Neve, and E. J. Nestler
Phospholipase C{gamma} in Distinct Regions of the Ventral Tegmental Area Differentially Modulates Mood-Related Behaviors
J. Neurosci., August 20, 2003; 23(20): 7569 - 7576.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Bracci, D. Centonze, G. Bernardi, and P. Calabresi
Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons
J. Physiol., May 15, 2003; 549(1): 121 - 130.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Tao and S. B. Auerbach
Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
Z.-X. Xi and E. A. Stein
GABAergic MECHANISMS OF OPIATE REINFORCEMENT
Alcohol Alcohol., September 1, 2002; 37(5): 485 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Zangen, S. Ikemoto, J. E. Zadina, and R. A. Wise
Rewarding and Psychomotor Stimulant Effects of Endomorphin-1: Anteroposterior Differences within the Ventral Tegmental Area and Lack of Effect in Nucleus Accumbens
J. Neurosci., August 15, 2002; 22(16): 7225 - 7233.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. J. De Vries and T. S. Shippenberg
Neural Systems Underlying Opiate Addiction
J. Neurosci., May 1, 2002; 22(9): 3321 - 3325.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Rouge-Pont, A. Usiello, M. Benoit-Marand, F. Gonon, P. V. Piazza, and E. Borrelli
Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors
J. Neurosci., April 15, 2002; 22(8): 3293 - 3301.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Drouin, L. Darracq, F. Trovero, G. Blanc, J. Glowinski, S. Cotecchia, and J.-P. Tassin
alpha 1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates
J. Neurosci., April 1, 2002; 22(7): 2873 - 2884.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Melis, R. Camarini, M. A. Ungless, and A. Bonci
Long-Lasting Potentiation of GABAergic Synapses in Dopamine Neurons after a Single In Vivo Ethanol Exposure
J. Neurosci., March 15, 2002; 22(6): 2074 - 2082.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. A. Schad, J. B. Justice Jr., and S. G. Holtzman
Endogenous Opioids in Dopaminergic Cell Body Regions Modulate Amphetamine-Induced Increases in Extracellular Dopamine Levels in the Terminal Regions
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 932 - 938.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. S. Mogil and G. W. Pasternak
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. T. Williams, M. J. Christie, and O. Manzoni
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Physiol Rev, January 1, 2001; 81(1): 299 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. J. Grottick, P. J. Fletcher, and G. A. Higgins
Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1183 - 1191.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
S. L. Jinks and E. Carstens
Superficial Dorsal Horn Neurons Identified by Intracutaneous Histamine: Chemonociceptive Responses and Modulation by Morphine
J Neurophysiol, August 1, 2000; 84(2): 616 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-X. Xi and E. A. Stein
Increased Mesolimbic GABA Concentration Blocks Heroin Self-Administration in the Rat
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 613 - 619.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. L. Laorden, M. T. Castells, M. D. MartInez, P. J. MartInez, and M. V. Milanes
Activation of c-fos Expression in Hypothalamic Nuclei by {micro}- and {kappa}-Receptor Agonists: Correlation with Catecholaminergic Activity in the Hypothalamic Paraventricular Nucleus
Endocrinology, April 1, 2000; 141(4): 1366 - 1376.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Alreja, M. Shanabrough, W. Liu, and C. Leranth
Opioids Suppress IPSCs in Neurons of the Rat Medial Septum/Diagonal Band of Broca: Involvement of {micro}-Opioid Receptors and Septohippocampal GABAergic Neurons
J. Neurosci., February 1, 2000; 20(3): 1179 - 1189.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Gallegos, R.-S. Lee, J. R. Criado, S. J. Henriksen, and S. C. Steffensen
Adaptive Responses of gamma -Aminobutyric Acid Neurons in the Ventral Tegmental Area to Chronic Ethanol
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1045 - 1053.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-X. Xi and E. A. Stein
Baclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1369 - 1374.
[Abstract] [Full Text]


Home page
Psychosom. Med.Home page
G. Torres and J. M. Horowitz
Drugs of Abuse and Brain Gene Expression
Psychosom Med, September 1, 1999; 61(5): 630 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. J. Manzoni and J. T. Williams
Presynaptic Regulation of Glutamate Release in the Ventral Tegmental Area During Morphine Withdrawal
J. Neurosci., August 1, 1999; 19(15): 6629 - 6636.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K Lee, A K Dixon, I Gonzalez, E B Stevens, S McNulty, R Oles, P J Richardson, R D Pinnock, and L Singh
Bombesin-like peptides depolarize rat hippocampal interneurones through interaction with subtype 2 bombesin receptors
J. Physiol., August 1, 1999; 518(3): 791 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Werme, P. Thoren, L. Olson, and S. Brene
Addiction-Prone Lewis But Not Fischer Rats Develop Compulsive Running that Coincides with Downregulation of Nerve Growth Factor Inducible-B and Neuron-Derived Orphan Receptor 1
J. Neurosci., July 15, 1999; 19(14): 6169 - 6174.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. M. van Ree, M. A. F. M. Gerrits, and L. J. M. J. Vanderschuren
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
Pharmacol. Rev., June 1, 1999; 51(2): 341 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. R. Burkey, E. Carstens, and L. Jasmin
Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces Antinociception
J. Neurosci., May 15, 1999; 19(10): 4169 - 4179.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Shoji, J. Delfs, and J. T. Williams
Presynaptic Inhibition of GABAB-Mediated Synaptic Potentials in the Ventral Tegmental Area during Morphine Withdrawal
J. Neurosci., March 15, 1999; 19(6): 2347 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. L. Svingos, E. E. O. Colago, and V. M. Pickel
Cellular Sites for Dynorphin Activation of kappa -Opioid Receptors in the Rat Nucleus Accumbens Shell
J. Neurosci., March 1, 1999; 19(5): 1804 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E. E. Zvartau
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
Pharmacol. Rev., March 1, 1999; 51(1): 83 - 133.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. E. Hemby, C. Co, S. I. Dworkin, and J. E. Smith
Synergistic Elevations in Nucleus Accumbens Extracellular Dopamine Concentrations during Self-Administration of Cocaine/Heroin Combinations (Speedball) in Rats
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 274 - 280.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
S. Numan, S. B. Lane-Ladd, L. Zhang, K. H. Lundgren, D. S. Russell, K. B. Seroogy, and E. J. Nestler
Differential Regulation of Neurotrophin and trk Receptor mRNAs in Catecholaminergic Nuclei during Chronic Opiate Treatment and Withdrawal
J. Neurosci., December 15, 1998; 18(24): 10700 - 10708.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. P. Schneider, W. A. Eckert III, and A. R. Light
Opioid-Activated Postsynaptic, Inward Rectifying Potassium Currents in Whole Cell Recordings in Substantia Gelatinosa Neurons
J Neurophysiol, December 1, 1998; 80(6): 2954 - 2962.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. R. Smith, J.-K. Zubieta, M. G. del Carmen, R. F. Dannals, H. T. Ravert, H. A. Zacur, and J. J. Frost
Brain Opioid Receptor Measurements by Positron Emission Tomography in Normal Cycling Women: Relationship to Luteinizing Hormone Pulsatility and Gonadal Steroid Hormones
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4498 - 4505.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
A. Hayar and P. G. Guyenet
Pre- and Postsynaptic Inhibitory Actions of Methionine-Enkephalin on Identified Bulbospinal Neurons of the Rat RVL
J Neurophysiol, October 1, 1998; 80(4): 2003 - 2014.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L.-I Tsao, B. Ladenheim, A. M. Andrews, C. C. Chiueh, J. L. Cadet, and T.-P. Su
Delta Opioid Peptide [D-Ala2,D-leu5]Enkephalin Blocks the Long-term Loss of Dopamine Transporters Induced by Multiple Administrations of Methamphetamine: Involvement of Opioid Receptors and Reactive Oxygen Species
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 322 - 331.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
K. R. Svoboda and C. R. Lupica
Opioid Inhibition of Hippocampal Interneurons via Modulation of Potassium and Hyperpolarization-Activated Cation (Ih) Currents
J. Neurosci., September 15, 1998; 18(18): 7084 - 7098.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Tao, Z. Ma, and S. B. Auerbach
Alteration in Regulation of Serotonin Release in Rat Dorsal Raphe Nucleus after Prolonged Exposure to Morphine
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 481 - 488.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. F. Olive and N. T. Maidment
Opioid Regulation of Pallidal Enkephalin Release: Bimodal Effects of Locally Administered Mu and Delta Opioid Agonists in Freely Moving Rats
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1310 - 1316.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J.-Y. Chang, P. H. Janak, and D. J. Woodward
Comparison of Mesocorticolimbic Neuronal Responses During Cocaine and Heroin Self-Administration in Freely Moving Rats
J. Neurosci., April 15, 1998; 18(8): 3098 - 3115.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-X. Xi, S. A. Fuller, and E. A. Stein
Dopamine Release in the Nucleus Accumbens during Heroin Self-Administration Is Modulated by Kappa Opioid Receptors: An In Vivo Fast-Cyclic Voltammetry Study
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 151 - 161.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Noble and B. M. Cox
The Role of Dopaminergic Systems in Opioid Receptor Desensitization in Nucleus Accumbens and Caudate Putamen of Rat After Chronic Morphine Treatment
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 557 - 565.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
B. Bontempi and F. R. Sharp
Systemic Morphine-Induced Fos Protein in the Rat Striatum and Nucleus Accumbens Is Regulated by µ Opioid Receptors in the Substantia Nigra and Ventral Tegmental Area
J. Neurosci., November 1, 1997; 17(21): 8596 - 8612.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. L. Svingos, A. Moriwaki, J. B. Wang, G. R. Uhl, and V. M. Pickel
µ-Opioid Receptors Are Localized to Extrasynaptic Plasma Membranes of GABAergic Neurons and Their Targets in the Rat Nucleus Accumbens
J. Neurosci., April 1, 1997; 17(7): 2585 - 2594.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Bonci and J. T. Williams
Increased Probability of GABA Release during Withdrawal from Morphine
J. Neurosci., January 15, 1997; 17(2): 796 - 803.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. J. Malanga, J. Meng, W. W. Fleming, and D. A. Taylor
Chronic Morphine Treatment of Guinea Pigs Induces Nonspecific Sensitivity Changes in the Nucleus Tractus Solitarius In Vitro
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 16 - 23.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
K. Nader and D. van der Kooy
Deprivation State Switches the Neurobiological Substrates Mediating Opiate Reward in the Ventral Tegmental Area
J. Neurosci., January 1, 1997; 17(1): 383 - 390.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. T. Berhow, N. Hiroi, L. A. Kobierski, S. E. Hyman, and E. J. Nestler
Influence of Cocaine on the JAK-STAT Pathway in the Mesolimbic Dopamine System
J. Neurosci., December 15, 1996; 16(24): 8019 - 8026.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. E. Hyman
A Man With Alcoholism and HIV Infection
JAMA, September 13, 1995; 274(10): 837 - 843.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
W. A. Carlezon Jr, C. N. Haile, R. Coppersmith, Y. Hayashi, R. Malinow, R. L. Neve, and E. J. Nestler
Distinct Sites of Opiate Reward and Aversion within the Midbrain Identified Using a Herpes Simplex Virus Vector Expressing GluR1
J. Neurosci., March 1, 2000; 20(5): RC62 - RC62.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Carboni, A. Silvagni, M. T. P. Rolando, and G. Di Chiara
Stimulation of In Vivo Dopamine Transmission in the Bed Nucleus of Stria Terminalis by Reinforcing Drugs
J. Neurosci., October 15, 2000; 20(20): RC102 - RC102.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-